PTGS2 and cancer: However, COX-2 is commonly over expressed in the majority of cancers, including adenocarcinoma, squamous cell carcinoma (SCC), transitional cell carcinoma, endometrial carcinoma, cholangiocarcinoma, and hepatocellular carcinoma24,30–32.